Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

2.

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

3.

Virtual Reality Travel Reduces Cancer Pain.

4.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma

5.

Year in Review: Non-Small Cell Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot